One of the most common birth defects in the world is hearing loss. Every 1,000 babies are born with permanent hearing loss in one or both ears. Hearing loss can have a significant impact on a baby's development.
CapitalBio created Hereditary #Deafness Gene Detection Item using semiconductor sequencing technology. It can identify #100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection is more than 99.9 percent accurate.
The Bioelectron gene sequencer 4000 platform was created in collaboration with Thermo Fisher. It can detect 384 samples at the same time.
What is In Vitro Diagnostic Reagents?April 4, 2023In vitro diagnostic reagents refer to in vitro diagnostic reagents managed by medical device management, including reagents, reagent kits, calibration products, quality control products, etc. used for...view
The Development History of Genetic Sequencer InstrumentApril 4, 2023The first generation of DNA genetic sequencer technologyIn 1977, Sanger proposed the classic dideoxy nucleotide termination sequencing method. Subsequently, based on the Sanger method, in the mid-1980...view
What Is The Most Accurate Alcohol Metabolism Test?March 11, 2024In the intricate domain of diagnostic testing, the quest for accuracy and reliability is perpetual. Among the myriad of tests, those aimed at deciphering alcohol metabolism stand out for their critica...view
CapitalBio: Advancing Breast Cancer Research with Microarray ScannersFebruary 7, 2024Introduction to CapitalBio and BRCA Gene ResearchCapitalBio, a global leader in biotechnology, is making significant strides in breast cancer research with its advanced microarray scanners. These inst...view